Hepatitis C virus from ear piercing;Le piercing des oreilles responsable d'une contamination par le virus, de l'hépatite C

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 5, 2004, Pages 507-508

  Grasset, Denis ^a   Borderes, Corinne ^b   Escudie, Luc ^b   Carreiro, Miguel ^b   Busato, Florian ^b   Seigneuric, Christian ^b   Payen, Jean Louis ^b  

^a Centre Hospitalier Bretagne Atlantique   (France)

^b Centre Hospitalier de Montauban   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANALYTICAL EQUIPMENT; ARTICLE; CASE REPORT; DISINFECTION; EAR LOBE PIERCING; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; NONHUMAN; POLYMERASE CHAIN REACTION; SEROLOGY; SKIN INJURY; VIRAL CONTAMINATION; VIRUS TRANSMISSION;

EID: 3042587197     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(04)94977-9     Document Type: Article

References (9)

1. Bourlière M, Halfon P, Quentin Y, David P, Mengotti C, Portal I, et al. Covert transmission of hepatitis C virus during bloody fisticuffs. Gastroenterology 2000;119:507-11.
2. Yee LJ, Weiss HL, Langner RG, Herrera J, Kaslow RA, van Leeuwen DJ. Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance. BMC Infect Dis 2001;1:8.
3. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;334:1691-6.
4. Alter MJ. Hepatitis C virus infection in the United States. J Hepatol 1999;31(Suppl 1):88-91.
5. Luminet B, Guyonnet JP. Sécurité sanitaire, tatouages et piercing, des pratiques professionnelles à risque. BEH 2002;4:15-7.
6. Desenclos JC, Bourdiol-Razes M, Rolin B, Garandeau P, Ducos J, Bréchot C, et al. Hepatitis C in a ward for cystic fibrosis and diabetic patients: possible transmission by spring-loaded finger-stick devices for self-monitoring of capillary blood glucose. Infect Control Hosp Epidemiol 2001;22:701-7.
7. Rocca P, Bailly F, Chevallier M, Chevallier P, Zoulim F, Trépo C. Etude de seize cas d'hépatites C aiguë. Essai de traitement précoce par l'interféron alpha-2b ou interféron alpha-2b et ribavirine. Gastroenterol Clin Biol 2003;27:294-9.
8. Jaeckel E, Comberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001;345:1452-7.
9. Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, et al. Acute hepatitis C: high rate of both spontaneous and treatment-indicerd viral clearence. Gastroenterology 2003;125: 80-8.